Evidence map›Paper›PMID 28330891›Full record

ArticleJournal of clinical microbiology2017

Evaluation of the bioNexia Legionella Test, Including Impact of Incubation Time Extension, for Detection of Legionella pneumophila Serogroup 1 Antigen in Urine.

Paul Badoux, Sjoerd M Euser, Jacob P Bruin, Patrick P G Mulder, Ed P F Yzerman

Abstract readEvaluation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. CRP under 130 mg/L rules out the diagnosis of Legionella pneumophila serogroup 1 (URINELLA Study).European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Observational
  2. Comparison of Legionella K-set® and BinaxNOW® Legionella for diagnosing Legionnaires' disease on concentrated urine samples.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Paul BadouxRegional Public Health Laboratory Kennemerland, Boerhaavelaan, Haarlem, the Netherlands p.badoux@streeklabhaarlem.nl.
Sjoerd M EuserRegional Public Health Laboratory Kennemerland, Boerhaavelaan, Haarlem, the Netherlands.
Jacob P BruinRegional Public Health Laboratory Kennemerland, Boerhaavelaan, Haarlem, the Netherlands.
Patrick P G MulderRegional Public Health Laboratory Kennemerland, Boerhaavelaan, Haarlem, the Netherlands.
Ed P F YzermanRegional Public Health Laboratory Kennemerland, Boerhaavelaan, Haarlem, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we compared the bioNexia test (bioMérieux, Marcy-l'Étoile, France), a new immunochromatographic assay for the detection of

Indexed as

Antigens, BacterialBacteriological TechniquesChromatography, AffinityHumansLegionella pneumophilaLegionnaires' DiseaseSensitivity and SpecificitySerogroupTime FactorsUrineAntigens, BacterialLegionellaLegionnaires' diseaseurinary antigen test

Identifiers

PMID28330891
PMCPMC5442529

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.